Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Colorectal Neoplasms × Crizotinib × Clear all

Phase

Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 3 Neuroblastoma 2 Neoplasms 2 Lung Neoplasms 2 Glioblastoma 2 Recurrence 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colorectal Neoplasms 1 Castration-resistant Prostate Cancer 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Advanced Cancers 1 Advanced Cancer 1 Adenocarcinoma 1

Interventions

Fluorouracil 59 pembrolizumab 52 Cetuximab 51 Oxaliplatin 49 Bevacizumab 49 Irinotecan 48 Leucovorin 47 Capecitabine 25 Nivolumab 19 Gemcitabine 16 Cisplatin 16 IFL protocol 15 Folfox protocol 15 Carboplatin 15 atezolizumab 14 Specimen Handling 14 Paclitaxel 14 Cyclophosphamide 14 Biopsy 13 Magnetic Resonance Spectroscopy 12 trifluridine tipiracil drug combination 11 Pemetrexed 10 spartalizumab 9 regorafenib 9 trametinib 8 130-nm albumin-bound paclitaxel 8 fludarabine 7 durvalumab 7 Trifluridine 7 dehydroftorafur 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02510001 2021-07-13

MErCuRIC1

University of Oxford

Phase 1 Completed

82 enrolled 36 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡